| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 31 Oct 2026 | 28 Oct 2026 |
| Quarterly Results & Inter alia, to consider and approve:- 1) Approval for voluntary full redemption of 20,000 Listed NCDs of face value of Rs. 1,00,000 each. 1) Unaudited Financial Results of the Company for the quarter and half year ended 30-09-2026 2) Statement of Deviation/Variation in utilization of funds for the quarter ended 30-09-2026 ; 3) Increase in threshold for granting loans/ICDs, providing of corporate guarantees/ securities, and making of investments in securities upto Rs. 500 crore 4) Material RPT which may be entered into by and between the Company and Neogen Morita New Materials Limited 5) Material RPT which may be entered into by and between Neogen Ionics Limited and NML; 6) The pre-mature (Voluntary) early redemption, in full of outstanding 20,000 NCDs having a face value of Rs. 1,00,000 each aggregating to INR 200 crore; 7) Approval the Postal Ballot Notice 8) Expanding the existing Organo-Lithium chemicals manufacturing facility from 300 MT/PA of active to 600 MT/PA of active at Patancheru, Telangana and other matters approved by the Board of subsidiaries. (As Per BSE Announcement Dated on:31.10.2026) | ||
| Board Meeting | 24 Jul 2026 | 20 Jul 2026 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 inter alia to consider and approve a) approval of un-audited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026. b) approval for issuance of securities through permissible modes of fund-raising Approval of financials for the quarter ended 30-06-2026, statement of deviation / variation, approved integrated annual report for fy 2025-26, fixing cut off date and book closure period, convening of AGM, inprinciple approval for raising of funds, appointment of internal auditors and other. (As Per BSE Announcement Dated on: 24/07/2026) | ||
| Board Meeting | 16 May 2026 | 12 May 2026 |
| Neogen Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve 1) Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended on March 31, 2026; 2) Recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2026, subject to declaration and approval of the same by the shareholders at the ensuing 37th Annual General Meeting. Approval of Audited Financial Results (Standalone and Consolidated) of the Company Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2026 and Asset cover certificate, recommendation of final dividend, Amendments to the Code for prevention of insider trading in the securities of Neogen Chemicals Limited,4. Details of Outstanding Qualified Borrowings and Incremental Qualified Borrowings for F.Y. 2025-26 and Other regulation 30 announcement. (As Per BSE Announcement Dated on: 16/05/2026) | ||
| Board Meeting | 7 Mar 2026 | 4 Mar 2026 |
| Preferential Issue of shares & Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares on preferential basis and other connected matters. Outcome of board meeting approving issue of 1000000 equity shares on preferential issue basis and approving Notice of EGM and related timelines. (As Per BSE Announcement Dated on:07.03.2026) | ||
| Board Meeting | 11 Feb 2026 | 6 Feb 2026 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on February 11 2026. Outcome of Board meeting approving unaudited financial results of the company for the quarter and nine months ended 31-12-2025. (As per BSE announcement dated on : 11.02.2026) | ||
| Board Meeting | 8 Nov 2025 | 5 Nov 2025 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Intimation of Board meeting to be held on November 8 2025 Outcome of Board meeting (As Per BSE Announcement Dated on 08.11.2025) | ||
Solid LiPF6 salt is a critical raw material for making electrolyte used in lithium-ion batteries, placing the JV directly in a high-demand supply chain.
The company added that the securities will be backed through hypothecation and mortgage, creating a subservient charge on assets.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
